NYSE: CAH

Deals Medical Device

Cardinal Health Acquires MedAlliance for $1.135 Billion to Enhance Vascular Intervention Portfolio

Fineline Cube Oct 7, 2023

US-based Cardinal Health (NYSE: CAH) has announced the acquisition of Swiss firm MedAlliance for a...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod